{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:59:58Z","timestamp":1762541998957},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.psychres.2011.04.004","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T10:16:31Z","timestamp":1306059391000},"page":"315-319","source":"Crossref","is-referenced-by-count":23,"title":["Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine"],"prefix":"10.1016","volume":"188","author":[{"given":"Ana Paula","family":"Werneck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime Cecilio","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio","family":"Elkis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2011.04.004_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.191.50.s1","article-title":"Evolution of outcome measures in schizophrenia","volume":"191","author":"Burns","year":"2007","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/bjp.191.50.s37","article-title":"Hospitalisation as an outcome measure in schizophrenia","volume":"191","author":"Burns","year":"2007","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S1516-44462007000300004","article-title":"Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine","volume":"29","author":"Castro","year":"2007","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1016\/j.psychres.2011.04.004_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10401230309085667","article-title":"Rehospitalization risk with second-generation and depot antipsychotics","volume":"15","author":"Conley","year":"2003","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/ajp.156.6.863","article-title":"Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine","volume":"156","author":"Conley","year":"1999","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.psc.2007.04.001","article-title":"Treatment-resistant schizophrenia","volume":"30","author":"Elkis","year":"2007","journal-title":"The Psychiatric Clinics of North America"},{"key":"10.1016\/j.psychres.2011.04.004_bb0035","first-page":"683","article-title":"Clozapine's effectiveness for patients in state hospitals: results from a randomized trial","volume":"32","author":"Essock","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.psychres.2011.04.004_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)07283-5","article-title":"An overview of clinical research: the lay of the land","volume":"359","author":"Grimes","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2011.04.004_bb0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1590\/S1516-44462007000300007","article-title":"Clinical aspects of super-refractory schizophrenia: a 6-month cohort observational study","volume":"29","author":"Henna","year":"2007","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1016\/j.psychres.2011.04.004_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3325\/cmj.2008.2.215","article-title":"Two-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs retrospective cohort study","volume":"49","author":"Herceg","year":"2008","journal-title":"Croatian Medical Journal"},{"key":"10.1016\/j.psychres.2011.04.004_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1192\/bjp.175.3.217","article-title":"Pragmatic randomized controlled trials in psychiatry","volume":"175","author":"Hotopf","year":"1999","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0060","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1017\/S0033291709005455","article-title":"Second-generation antipsychotics for schizophrenia: can we resolve the conflict?","volume":"39","author":"Leucht","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2011.04.004_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia","volume":"32","author":"Lewis","year":"2006","journal-title":"Schizophrenia Bulletin"},{"issue":"12","key":"10.1016\/j.psychres.2011.04.004_bb0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.psychres.2011.04.004_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1726-4901(09)70254-0","article-title":"Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone","volume":"69","author":"Lin","year":"2006","journal-title":"Journal China Medical Association"},{"key":"10.1016\/j.psychres.2011.04.004_bb0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0085","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpsyc.1991.01810320088015","article-title":"A polydiagnostic application of operational criteria in studies of psychotic illness","volume":"48","author":"McGuffin","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1176\/ajp.154.4.475","article-title":"Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance","volume":"154","author":"Meltzer","year":"1997","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.04.004_bb0095","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1176\/appi.ps.53.7.891","article-title":"One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics","volume":"53","author":"Patel","year":"2002","journal-title":"Psychiatric Service"},{"key":"10.1016\/j.psychres.2011.04.004_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1176\/appi.ajp.158.2.266","article-title":"Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics","volume":"158","author":"Rabinowitz","year":"2001","journal-title":"The American Journal of Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811100285X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811100285X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T17:24:33Z","timestamp":1543771473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811100285X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S016517811100285X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2011.04.004","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}